Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV) - Image 1

£141.04

Springer Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV)

Name: Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV)
Brand: Springer
Price: 141.04 GBP
Availability: InStock

Pharmacy - Dispensing

This is the most expensive it has ever been. Walk away.

£141 today · previous high £141 · all-time low £140

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 583 days • 583 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 583 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £141 (498 days, 85.4%)

Price range: £140 - £141

Price levels: 2 different prices over 583 days

Description

Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, “drug-like” properties refer to the molecule’s physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1493950479
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 25 October 2016
Listed Since: 03 November 2016

Barcode

No barcode data available

Springer Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Fundamentals of Drug Development

Case Studies in Modern Drug Discovery and Development

Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)

Integration of Pharmaceutical Discovery and Development: Case Histories: 11 (Pharmaceutical Biotechnology, 11)

Industrialization of Drug Discovery: From Target Selection Through Lead Optimization: 2 (Drug Discovery Series)

Comprehensive Medicinal Chemistry II, Volume 1: GLOBAL PERSPECTIVE

The Ups and Downs in Drug Design: Adventures in Medicinal Chemistry

Tactics in Contemporary Drug Design: 9 (Topics in Medicinal Chemistry, 9)

Pharmazeutische/Medizinische Chemie: Arzneistoffe - von der Struktur zur Wirkung

Drug-Like Properties: Concepts, Structure Design and Methods from Adme to Toxicity Optimization

The Ups and Downs in Drug Design: Adventures in Medicinal Chemistry

Artificial Intelligence for Drug Product Lifecycle Applications

Drug Discovery Stories: From Bench to Bedside

Wiley - Contemporary Accounts in Drug Discovery and Development

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Drugs and a Methodological Compendium: From bench to bedside

Medicinal Chemistry: A Look at How Drugs Are Discovered

The Science and Business of Drug Discovery: Demystifying the Jargon

Overcoming Obstacles in Drug Discovery and Development: Surmounting the Insurmountable―Case Studies for Critical Thinking

Drugs: From Discovery to Approval

Translating Molecules into Medicines: Cross-Functional Integration at the Drug Discovery-Development Interface: 25 (AAPS Advances in the Pharmaceutical Sciences Series, 25)

The Science and Business of Drug Discovery: Demystifying the Jargon

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

The Science and Business of Drug Discovery: Demystifying the Jargon